Biomedical subjects
C E Reed
Publications and source records attributed to C E Reed.
Prevention of antigen-induced bronchoconstriction by lodoxamide ethyl, a new orally active antiallergic drug.
Lodoxamide ethyl, an orally active drug with pharmacologic activity similar to that of cromolyn sodium, blocks passive cutaneous anaphylaxis (PCA) in rats and antigen-induced bronchoconstriction in guinea pigs and monkeys. Its effectiveness in preventing antigen-induced airway obstruction was studied in 12 asymptomatic asthmatic adults with immediate skin test sensitivity to ragweed, Alternaria, or animal dander. The dose required to reduce the forced expiratory volume in 1 sec (FEV1) by 20% (PD20) was determined by dosimeter bronchoprovocation challenge with the appropriate antigen. At 1-wk intervals each subject received either placebo of 1, 3, or 10 mg drug in a randomized, double-blind fashion 30 min prior to starting bronchoprovocation challenge. On average, 1 mg increased the PD20 fivefold, 3 mg about sixfold, and 10 mg about 27-fold. Dose-related side effects began 10 min after drug and lasted up to 40 min. Thus the oral administration of lodoxamide ethyl was effective in preventing antigen-induced bronchoconstriction, and both the beneficial effects and side effects are dose related.
Multicenter study of flunisolide aerosol in adult patients with steroid-dependent asthma.
Seventy-three adult, steroid-dependent asthmatic patients participated in a 16-wk, double-blind study testing the efficacy of flunisolide aerosol. Forty received flunisolide, and 33 received placebo. The mean daily prednisone requirement of patients receiving flunisolide fell 59.2% during the testing period, and that of the patients receiving placebo fell 19.7%. The median daily prednisone dose dropped 74.4% in the flunisolide group and 4.2% in the placebo group (p = 0.006). In the flunisolide group 75% tapered use of oral steroids 50% or more, and 27.5% stopped taking oral steroids completely. In the placebo group 36% tapered use of oral steroids 50% or more, and only 12% stopped taking them completely. Despite their reduction in systemic steroids, those patients receiving flunisolide achieved significantly greater reduction in the daily severity of wheezing (p = 0.014) and frequency of asthma attacks (p = 0.049) than did those receiving placebo. In the final evaluation of therapeutic response, 70% of patients receiving flunisolide were rated as having a very good or good response, and 30% were rated as having a fair or poor response. In contrast 33% of patients receiving placebo were rated as very good or good, and 67% were rated as fair or poor (p = 0.0009). No serious reactions were reported. Plasma cortisols showed an average increase of 42.9% in the flunisolide group but no change in the placebo group. Flunisolide aerosol is a well-tolerated and effective agent in the treatment of steroid-dependent asthma.
HLA antigen frequencies and natural history in Alternaria-sensitive and perennial nonallergic asthmatics.
The frequency of HLA-A, -B, and -C loci antigens in random populations of Alternaria-sensitive (N = 100) and perennial nonallergic asthmatics (N = 87) were compared with age- (+/- 5 yr) and sex-matched controls from the same geographic region. There was no association between HLA antigens as measured by frequency analyses and Alternaria-sensitive or perennial nonallergic asthma. Moreover there was no association between HLA antigens and the age of onset of asthma, associated allergic disorders, various environmental factors provoking asthma, total serum IgE levels, and Alternaria-specific IgE antibody.
Effect of iodoxamide ethyl on allergy skin tests.
Lodoxamide ethyl is a new cromolyn-like drug which prevents antigen-induced mediator release from mast cells and antigen-induced bronchoconstriction in sensitive animals and man. The purpose of this study was to determine the effect of a single administration of lodoxamide ethyl on allergy skin tests. The effect of this drug on allergy skin testing was studied in a double-blind design on ten adult subjects allergic to ragweed. Serial end-point titrations with short ragweed extract and with histamine were performed after a placebo and 1- and 3-mg capsules of lodoxamide ethyl. The immediate wheal-and-flare responses as well as the late allergic reaction were recorded. No statistically significant difference was found between lodoxamide ethyl and placebo in the suppression of the allergen-induced immediate wheal-and-flare response or the late allergic reaction. Furthermore, 1 and 3 mg of oral lodoxamide ethyl did not inhibit the histamine-induced cutaneous reactions.
Nylon stocking dermatitis. An unusual example.
We report herein a woman sensitive to nylon stockings of only brown or tan shade. Her situation is interesting for several reasons: she does not react to paraphenylediamine and she reacts to red and yellow dyes, but not to blue or the finish; however, when finish is applied to dyed blanks (red, yellow, or blue) she reacts vigorously to all three. We suspect the finish reacts with the dyes to either expose or produce an antigen previously not available to the skin.
Suppressive effect of catecholamines on 19-S antibody formation in mouse spleen fragments in vitro.
Spleen fragments of Balb/C mice were immunized with sheep red blood cells in vitro and hemolytic plaque forming cells (PFC) were assayed on the 5th day of immunization. Epinephrine in culture medium diminished the number of PFC dose-dependently over the range from 10(-6) M to 2.7 X 10(-4) M. Incubation with 9 X 10(-5) M epinephrine diminished PFC response only when the epinephrine was present on the first day of the culture. No suppression was found for treatment during any other 24-hr periods. Three beta-adrenergic stimulating catecholamines, epinephrine, isoproterenol, and norepinephrine, suppressed PFC response in similar degree. It is concluded that beta-adrenergic stimulation suppressed 19-S antibody formation mainly by inhibiting induction of immune response.
In vitro studies on the mechanism of respiratory virus-induced asthma.
Explore the source record for details and available documents.
A survey of patient education program in Michigan hospitals.
Explore the source record for details and available documents.
The effects of air cleaners on hay fever symptoms in air-conditioned homes.
Explore the source record for details and available documents.
Bronchodilating effect of oral theophylline-ephedrine combination.
Explore the source record for details and available documents.
Antibody-dependent cellular cytotoxicity of mononuclear cells from asthmatics tested in three in vitro assays.
Using the chicken red blood cell assay, the human Chang liver cell assay, and a lymphoblastoid cell assay, mononuclear cells from asthmatics and normals were tested for antibody-dependent cellular cytotoxicity (ADCC) capacity. Mononuclear cell preparations from perennial nonallergic asthmatics with a history of asthma associated with viral infections had a reduced ADCC capacity in the chicken red blood cell assay, an increased ADCC capacity in the Chang liver cell assay, and normal ADCC capacity in the lymphoblastoid cell assay. The data also suggested that perennial nonallergic asthmatics had increased percentages of surface IgG-negative lymphocytes in the peripheral blood when compared to normals.
Terbutaline's effects on the allergy skin test.
Beta adrenergic agents are known to inhibit mediator release from skin and lung mast cells in vitro and isoproterenol and epinephrine are known to impair the immediate allergic skin test reaction. We undertook to investigate the effects of aqueous and oral terbutaline on the allergy skin tests. We particularly wished to analyze the impact of terbutaline on the late allergic reaction, but we found that terbutaline mixed with ragweed antigen does not affect either the immediate or late skin test reaction. Furthermore, 5 mg of oral terbutaline does not inhibit the immediate allergic skin test.
Allergic bronchopulmonary aspergillosis.
Explore the source record for details and available documents.
Effects of experimental rhinovirus 16 infection on airways and leukocyte function in normal subjects.
We infected 7 normal volunteers with rhinovirus 16. In general, the symptoms and alterations in airways were minimal although all subjects had upper respiratory symptoms. Three subjects developed in addition lower respiratory and systemic symptoms accompanied by either an increase in the volume of isoflow or a positive methacholine response. Furthermore, these three had a decrease in beta adrenergic and H2 histamine receptor responses of their granulocytes. Since the peripheral airway obstruction and decreased beta adrenergic and H2 histamine responses occurred together, these two phenomenon may have a common cause. All seven subjects had a decrease in number of circulating E rosette-forming lymphocytes, and in 6 of 7, there was a decrease in the antibody-dependent cellular cytotoxicity capacity of mononuclear cell preparations. It is not clear whether these changes reflect redistribution of mononuclear cells or alteration of their function.
HLA antigen frequencies in allergic bronchopulmonary aspergillosis.
The frequency of HLA antigens in twenty-two Caucasian patients with allergic broncho-pulmonary aspergillosis (ABPA) and sixty-nine unrelated Caucasian controls was determined. The results indicated that there was no increased frequency of a specific HLA antigen in patients with ABPA. Moreover, studies in thirteen families of ABPA patients also demonstrated that, within families, there was no consistent association between a specific haplotype and asthma, allergies or hay fever.
Asthma due to African zebrawood (Microberlinia) dust.
Inhalation of wood dusts can cause immediate and late onset asthma. The list of woods responsible for such reactions is continually increasing. We report a patient with asthma induced by exposure to the dust of African zebrawood (genus Microberlinia). Sensitivity to this dust was confirmed by immediate skin-test reactivity, a positive bronchial challenge, and a positive radio allergo-sorbent test to an aqueous extract. The bronchial response was inhibited by sodium cromoglycate. Unexposed persons did not exhibit skin or bronchial reactivity.
The absence of a relationship between serum precipitins and pulmonary disease in a community.
To study the role of serum precipitins in respiratory illness in a community, sera obtained from 3,047 residents of Tucson, Ariz., were tested for the presence of precipitating antibody to a battery of antigens. Positive reactions were obtained in 54 subjects (1.8 percent), a lower incidence than has been reported previously. The majority of these subjects were older than 54 years of age, an age distribution significantly older than the entire sample (P less than 0.01). Pulmonary function among the subjects with positive precipitin reactions was not significantly different from that of the asymptomatic nonsmokers of the entire sample. None of the subjects who were lifelong residents of Arizona had serum precipitins to any of the thermophilic actinomycetes antigens which were used in the testing. These antigens have been found in association with extrinsic allergic alveolitis, most frequently among patients living in the north central United States and were derived from strains of Micropolyspora faeni, Thermoactinomycetes candidus and vulgaris. Each subject with precipitins to one or more of the tested antigens was matched by age, sex, and socioeconomic class with two subjects from the sample who had negative precipitin reactions. The groups did not differ in their prevalence of respiratory symptoms or abnormalities of pulmonary function. We conclude that the presence of precipitating serum antibodies among subjects in a community is not indicative of the presence of immunologic pulmonary disease but merely reflects previous exposure to the tested antigen. In addition, individuals whose sera contain precipitating antibody appear to have no increased tendency to develop other types of pulmonary disease.